Citizens Financial Group Inc 180 Life Sciences Corp. Transaction History

Citizens Financial Group Inc

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 10, 2022	BUY	$3.27 - $6.38 $430,904 - $840,724	131,775 New	131,775 $514,000

Ticker ATNF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,698,900
Market Cap $81.1M
Description
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.